Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Synthes Inc."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Synthes Inc.."

6 result(s) displayed (1 - 6 of 6)


J&J to consider sale of Ortho Clinical Diagnostics

The medical technology giant says it would consider its options for the unit and warned that it may not make any deal at all involving it. Continue reading

Posted on January 22, 2013 4:26 PM




FTC likely to approve J&J-Synthes deal

After a year under review, the $21 billion merger could be approved this week Continue reading

Posted on May 30, 2012 4:14 PM




EC approves J&J's Synthes acquisition

To purchase the Swiss-American orthopedic device maker, the healthcare giant agrees to allay competition concerns by selling its trauma business. Continue reading

Posted on April 19, 2012 2:20 PM




EC launches in-depth probe of J&J's Synthes takeover

Competition chief Almunia says the $21.3 billion medical devices transaction would remove a competitor from markets which are already concentrated. Continue reading

Posted on November 4, 2011 8:57 AM




VIDEO: Kinetic LBO only the start of medtech M&A

The $6.3 billion LBO of medical device maker Kinetic Concepts by an Apax Partners-led consortium is 'probably the beginning of a good two or three year run of run' in medtech, says Piper Jaffray's Matt Miksic. Continue reading

Posted on August 2, 2011 1:51 PM




Deal diary: May 9-22, 2011

Copper and utilities remain hot commodities for dealmakers, J&J taps old friends for Synthes, Kirkland & Ellis wheels in Teva, and CenturyLink hits the deal trail again. Continue reading

Posted on May 6, 2011 12:45 PM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Alvarez & Marsal tapped Graeme Ashley-Fenn as head of its regulatory advisory practice in London. For other updates launch today's Movers & shakers slideshow.

Video

JPMorgan's stark choice

Jamie Dimon has earned his shareholders' confidence and loyalty. Now, what else can he do? More video

Sectors